Advances in Cancer Clinical Trials

Print icon

It’s frightening to receive a cancer diagnosis. But there is more hope than ever before: clinical trials have been a key part of cancer patients living longer with better outcomes. Dr. Peter Yu is physician-in-chief at the Hartford HealthCare Cancer Institute, a charter member of the Memorial Sloan Kettering Cancer Alliance. He talks about the importance of cancer clinical trials, and what they mean for cancer care, both now and in the future. 

Q: What is the impact of clinical research – particularly cancer clinical trials – in patient treatment today?

A: There are more patients being cured and living longer than ever before. But that’s a testament to the clinical trials that have been going on for the past few decades. Without those clinical trials, we would not have the treatments that are working so well today. And we need to continue to do clinical trials because we need to continue to have better treatments and have patients live longer and with better quality of life.

Q: What is your response to patients and their family members who may be afraid of the phrase “clinical trial?”

A: I would say the number one worry that people have about clinical trials is placebo. They will ask “How do I know that I’m not gonna get some dummy treatment or sugar pill?”

The fact of the matter is that that is very, very rare today because of all the successes we’ve had in treatment. So it’s almost unthinkable that there would be no option whatsoever. What we often do today is a randomization, where the patient will get some treatment versus some experimental treatment. And that some treatment is what we call the current standard of care, or the best available care to our knowledge, but it’s usually not the best treatment that we hope to have someday. Every patient with cancer, working together with their healthcare team, with other patients around the country to advance cures.

Learn more about the clinical cancer trials available through the Hartford HealthCare Cancer Institute alliance with Memorial Sloan Kettering Cancer Center here

What's New

Flu Season

Here’s What’s in Your Flu Vaccine: Will It Work This Season?

Wasn’t it just yesterday that we were sunning ourselves at Hammonasset Beach? Actually, yes it was, but now it’s officially fall and we only care about one thing — the coming flu season. Predicting the severity of a flu season isn’t like predicting which team will win more football games, the...

Heart & aspirin.

Baby Aspirin a Day for Your Heart? Not For Everyone

While about 50 percent of older American adults take aspirin regularly to ward off heart disease, a new study reveals that the practice may actually cause more harm than good for healthy people. Dr. Paul Thompson, chief of cardiology and physician co-director of the Hartford HealthCare Heart & Vascular Institute,...


Study: MitraClip Device a ‘Game-Changer’ for Heart-Failure Patients

Until now, patients with serious heart failure caused by leaky valves were treated so they felt a little better but the disease relentlessly stunted their life expectancy relentlessly. Recent research published in the New England Journal of Medicine, however,  gives hope to these patients, according to Dr. Sabet Hashim, chair...


Report: Up to 75 Percent of Patients Don’t Take Meds as Prescribed

“Devastating” and “staggering (toll)” are adjectives used by officials with the National Council for Behavioral Health’s Medical Director Institute, or MDI, on its recent report showing a grave lack of compliance to medication prescriptions. Noncompliance with medication regimens — when people do not take prescription drugs as prescribed by their...

Kids, Social Media and Body Image

Raising teens to have a positive body image isn’t easy. And it seems to have become more complicated in the age of Snapchat and Instagram, where selfies can be filtered to perfection. Plastic surgeons have even reported that patients are visiting their practices with filtered social media images and asking...

Assessing the Hereditary Risk of Cancer

A new hereditary cancer risk assessment program is helping identify specific cancers in women and men across Connecticut. Hartford HealthCare nurse practitioner Meghan Burgess explains the importance of this program. Q: Why is it so important to have this type of assessment program? A: We’re identifying women at risk for...

What is Precision Medicine in Breast Cancer Treatment?

Precision medicine allows doctors to treat patients based on their individual biology. Dr. Camelia Lawrence is the director of breast surgery at the Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut and MidState Medical Center. She explains how precision medicine is used in treating breast cancer.  Q: What is precision medicine? A:...